Tuesday Aug 19
Arca Biopharma (ABIO) Announces Quarterly Results
Arca Biopharma announced its earnings results on Tuesday. The company reported EPS for the quarter, beating the Thomson Reuters consensus estimate of by $0.02, AmericanBankingNews.com reports.
View Press Release
ARCA anticipates that clinical trial sites in Canada will be active in the fourth quarter of 2014.
ARCA Biopharma: An Undervalued Biotech With A Bright Future
ARCA biopharma has close to $22 million cash on hand, which represents 70% of the company's market cap and a cash runway through 2015.
Arca Biopharma, Inc. Files (8-K) Disclosing Submission of Matters to...
ARCA BIOPHARMA, INC. FILES Disclosing Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits , the Company held it's 2014 Annual Meeting of Stockholders at which the Company's stockholders voted upon the election of Company nominees Dr. , to the Company's Board of Directors for a three-year term ending ... (more)
Robert E. Conway Elected Chairman of ARCA biopharma Board of Directors
He serves on the Audit and Compensation Committees of the Board of Directors. served as the Chief Executive Officer and member of the Board of Directors of Array BioPharma from 1999 to 2012.